Annual sunscreen expenses fluctuated between $40 and $1400 based on product pricing and concurrent sun-protective behaviors.

Patients with chronic back pain reported heightened unpleasantness of auditory stimuli and mechanical pressure.

The FDA accepted a New Drug Application with Priority Review for brepocitinib, an oral TYK2/JAK1 inhibitor, for the treatment of dermatomyositis.

Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.

Obinutuzumab was superior to placebo for systemic lupus erythematosus in a phase 3 trial, significantly improving SRI-4 response rates.

Early sport specialization was associated with more hip or groin pain, surgical treatment of the hip, and quitting the sport due to injury. HealthDay News — Repetitive stress from early single-sport ...

Treatments for Alzheimer disease agitation, focal segmental glomerulosclerosis, hematological malignancies, HIV-1, and obesity are under review.

The FDA grants Fast Track designation to nipocalimab for systemic lupus erythematosus following positive results from the phase 2b JASMINE trial.

Robotic-assisted total knee arthroplasty was associated with improved patient satisfaction and quality of life vs conventional surgery.

Testosterone replacement therapy before total knee arthroplasty was linked to higher risks for systemic and periprosthetic complications.

Higher SUA levels were associated with a lower risk for osteoporosis, with sex, race, diabetes status, and serum cholesterol ...

Adults with overweight or obesity regained most weight lost during GLP-1 receptor agonist treatment at 1 year following cessation.